Literature DB >> 31757572

Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy).

Enrico Longato1, Barbara Di Camillo1, Giovanni Sparacino1, Claudio Saccavini2, Angelo Avogaro3, Gian Paolo Fadini4.   

Abstract

BACKGROUND AND AIMS: Diabetes can often remain undiagnosed or unregistered in administrative databases long after its onset, even when laboratory test results meet diagnostic criteria. In the present work, we analyse healthcare data of the Veneto Region, North East Italy, with the aims of: (i) developing an algorithm for the identification of diabetes from administrative claims (4,236,007 citizens), (ii) assessing its reliability by comparing its performance with the gold standard clinical diagnosis from a clinical database (7525 patients), (iii) combining the algorithm and the laboratory data of the regional Health Information Exchange (rHIE) system (543,520 subjects) to identify undiagnosed diabetes, and (iv) providing a credible estimate of the true prevalence of diabetes in Veneto. METHODS AND
RESULTS: The proposed algorithm for the identification of diabetes was fed by administrative data related to drug dispensations, outpatient visits, and hospitalisations. Evaluated against a clinical database, the algorithm achieved 95.7% sensitivity, 87.9% specificity, and 97.6% precision. To identify possible cases of undiagnosed diabetes, we applied standard diagnostic criteria to the laboratory test results of the subjects who, according to the algorithm, had no diabetes-related claims. Using a simplified probabilistic model, we corrected our claims-based estimate of known diabetes (6.17% prevalence; 261,303 cases) to account for undiagnosed cases, yielding an estimated total prevalence of 7.50%.
CONCLUSION: We herein validated an algorithm for the diagnosis of diabetes using administrative claims against the clinical diagnosis. Together with rHIE laboratory data, this allowed to identify possibly undiagnosed diabetes and estimate the true prevalence of diabetes in Veneto.
Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Administrative claims; Diabetes; Health information exchange; Laboratory reports; Prevalence; Undiagnosed diabetes; Veneto

Mesh:

Year:  2019        PMID: 31757572     DOI: 10.1016/j.numecd.2019.08.017

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  13 in total

1.  Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory.

Authors:  Enzo Bonora; Salvatore Cataudella; Giulio Marchesini; Roberto Miccoli; Olga Vaccaro; Gian Paolo Fadini; Nello Martini; Elisa Rossi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

2.  Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life.

Authors:  Enrico Longato; Barbara Di Camillo; Giovanni Sparacino; Lorenzo Gubian; Angelo Avogaro; Gian Paolo Fadini
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06

Review 3.  Diabetes and COVID-19.

Authors:  Béatrice Bouhanick; Jean-Luc Cracowski; Jean-Luc Faillie
Journal:  Therapie       Date:  2020-05-15       Impact factor: 2.070

4.  [Diabetes and COVID-19].

Authors:  Béatrice Bouhanick; Jean-Luc Cracowski; Jean-Luc Faillie
Journal:  Therapie       Date:  2020-04-23       Impact factor: 2.070

5.  Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study.

Authors:  Enrico Longato; Barbara Di Camillo; Giovanni Sparacino; Lara Tramontan; Angelo Avogaro; Gian Paolo Fadini
Journal:  Cardiovasc Diabetol       Date:  2021-11-13       Impact factor: 9.951

6.  Diabetes Mellitus Diagnosis and Screening in Australian General Practice: A National Study.

Authors:  Mingyue Zheng; Carla De Oliveira Bernardo; Nigel Stocks; David Gonzalez-Chica
Journal:  J Diabetes Res       Date:  2022-03-23       Impact factor: 4.011

7.  Prevalence and impact of diabetes among people infected with SARS-CoV-2.

Authors:  G P Fadini; M L Morieri; E Longato; A Avogaro
Journal:  J Endocrinol Invest       Date:  2020-03-28       Impact factor: 4.256

Review 8.  COVID-19 and diabetes: Knowledge in progress.

Authors:  Akhtar Hussain; Bishwajit Bhowmik; Nayla Cristina do Vale Moreira
Journal:  Diabetes Res Clin Pract       Date:  2020-04-09       Impact factor: 8.180

Review 9.  Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?

Authors:  Giuseppe Pugliese; Martina Vitale; Veronica Resi; Emanuela Orsi
Journal:  Acta Diabetol       Date:  2020-08-31       Impact factor: 4.280

10.  Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.

Authors:  Mario Luca Morieri; Valentina Perrone; Chiara Veronesi; Luca Degli Esposti; Margherita Andretta; Mario Plebani; Gian Paolo Fadini; Saula Vigili de Kreutzenberg; Angelo Avogaro
Journal:  Cardiovasc Diabetol       Date:  2021-07-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.